Filing Details

Accession Number:
0001209191-20-040944
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-06 14:21:01
Reporting Period:
2020-07-01
Accepted Time:
2020-07-06 14:21:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1515673 Ultragenyx Pharmaceutical Inc. RARE Pharmaceutical Preparations (2834) 272546083
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1603347 Alan Theodore Huizenga C/O Ultragenyx Pharmaceutical Inc.
60 Leveroni Court
Novato CA 94949
Svp, Controller And Pao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-07-01 1,111 $81.00 17,220 No 4 S Direct
Common Stock Acquisiton 2020-07-01 1,500 $21.00 18,720 No 4 M Direct
Common Stock Disposition 2020-07-01 1,500 $81.00 17,220 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-07-01 1,500 $0.00 1,500 $21.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,000 2024-01-29 No 4 M Direct
Footnotes
  1. The exercise and sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
  3. 1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter.